AU6712090A - Drug delivery systems and matrix therefor - Google Patents

Drug delivery systems and matrix therefor

Info

Publication number
AU6712090A
AU6712090A AU67120/90A AU6712090A AU6712090A AU 6712090 A AU6712090 A AU 6712090A AU 67120/90 A AU67120/90 A AU 67120/90A AU 6712090 A AU6712090 A AU 6712090A AU 6712090 A AU6712090 A AU 6712090A
Authority
AU
Australia
Prior art keywords
drug delivery
delivery systems
matrix therefor
therefor
matrix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67120/90A
Inventor
Wattanaporn T Abramowitz
Ramchander Malhotra
Dilip R. Sanvordeker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actavis Laboratories UT Inc
Original Assignee
Actavis Laboratories UT Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actavis Laboratories UT Inc filed Critical Actavis Laboratories UT Inc
Publication of AU6712090A publication Critical patent/AU6712090A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F2013/00361Plasters
    • A61F2013/00902Plasters containing means
    • A61F2013/00906Plasters containing means for transcutaneous or transdermal drugs application

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU67120/90A 1989-10-13 1990-10-11 Drug delivery systems and matrix therefor Abandoned AU6712090A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42137889A 1989-10-13 1989-10-13
US421378 1989-10-13

Publications (1)

Publication Number Publication Date
AU6712090A true AU6712090A (en) 1991-05-16

Family

ID=23670271

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67120/90A Abandoned AU6712090A (en) 1989-10-13 1990-10-11 Drug delivery systems and matrix therefor

Country Status (2)

Country Link
AU (1) AU6712090A (en)
WO (1) WO1991005529A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
DE4210165A1 (en) * 1991-07-30 1993-02-04 Schering Ag TRANSDERMAL THERAPEUTIC SYSTEMS
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
DE4210711A1 (en) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De TRANSDERMAL THERAPEUTIC SYSTEMS WITH CRYSTALIZATION INHIBITORS
DE4237453C1 (en) * 1992-11-06 1993-08-19 Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De
DE4309830C1 (en) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Transdermal patches for oestradiol admin. - contg. isopropylidene mono- or di-glycerol as penetration enhancer
GR1002079B (en) * 1994-07-26 1995-12-05 Lavipharm A E System of a special structure and composition for the rapid transdermal administration of oestrogens.
DE4429663C2 (en) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Transdermal therapeutic system with hydrolysis protection
DE4429664C2 (en) * 1994-08-20 1997-09-11 Lohmann Therapie Syst Lts Estradiol TTS with water-binding additives and process for its preparation
US20060002949A1 (en) 1996-11-14 2006-01-05 Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. Transcutaneous immunization without heterologous adjuvant
EP0858805A3 (en) * 1997-02-13 1998-09-02 National Research Institute of Chinese Medicine Transdermal preparations of oxicams
PL335410A1 (en) * 1997-02-28 2000-04-25 Minnesota Mining & Mfg Medium for transcutaneous testosterone administration
DE10033853A1 (en) * 2000-07-12 2002-01-31 Hexal Ag Transdermal therapeutic system, containing highly dispersed silicon dioxide in matrix or adhesive layer to promote drug permeation through the skin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808414A (en) * 1986-09-29 1989-02-28 Nelson Research & Development Co. Amide penetration enhancers for transdermal delivery of systemic agents
FR2612785A1 (en) * 1987-03-25 1988-09-30 Lhd Lab Hygiene Dietetique SELF-ADHESIVE DEVICE FOR DELIVERY OF A PERCUTANEOUS ACTIVE INGREDIENT

Also Published As

Publication number Publication date
WO1991005529A1 (en) 1991-05-02

Similar Documents

Publication Publication Date Title
AU664807B2 (en) Drug delivery system
AU8935591A (en) Drug delivery system and method
AU4989993A (en) Drug delivery system
AU7170591A (en) Particulate delivery system
AU8263987A (en) Pharmaceutical Delivery Systems
AU6534894A (en) Drug administration system
AU576630B2 (en) Drug delivery system
AU6820687A (en) Drug delivery system
AU8933391A (en) Medical drug formulation and delivery system
AU5102893A (en) Automated order and delivery system
AU7676894A (en) Convection-enhanced drug delivery
AU1029595A (en) Collagen-based injectable drug delivery system and its use
AU3321293A (en) Polymer matrix drug delivery apparatus and method
GB8723846D0 (en) Bioadhesive microsphere drug delivery system
AU7673694A (en) Simultaneous angioplasty and drug delivery
AU7668894A (en) Hydrogel-based microsphere drug delivery systems
AU1917788A (en) Estradiol transdermal delivery system
AU7840994A (en) Active substance delivery system
AU7255394A (en) Monolithic matrix transdermal delivery system
AU1849988A (en) Drug delivery devices
AU643679B2 (en) Solid gel external drug delivery system
AU6712090A (en) Drug delivery systems and matrix therefor
AU660290B2 (en) Multiple drug delivery system
AU5260990A (en) Roboting drug dispensing system
AU7923794A (en) Iontophoretic drug delivery system and method